Thomas William Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas William Johnson has a total of 835 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Baumbach
Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom
19 shared publications - Barnaby C. Reeves
Bristol Medical School, University of Bristol, Bristol, UK
7 shared publications Julian W. Strange
7 shared publications- Chiara Bucciarelli-Ducci
Royal Brompton and Harefield Hospitals, Guys and St Thomas NHS Foundation Trust , London SW3 6NP
6 shared publications - Julian Strange
Department of Cardiology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
6 shared publications - Yongcheol Kim
Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Yongin, Korea
6 shared publications
Latest Publications
- 29 September 2026
- Published by Elsevier in American Heart Journal
- Vol. 304
Periprocedural myocardial infarction and clinical outcomes in diffuse vs focal coronary artery disease
- 29 September 2026
- Published by Elsevier in American Heart Journal
- Vol. 304
Periprocedural myocardial infarction and clinical outcomes in diffuse vs focal coronary artery disease
- Open Access
- 9 September 2026
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
Five Practical Considerations for the Management of Out-of-hospital Cardiac Arrest: Reflections from the British Cardiovascular Intervention Society Out-of-hospital Cardiac Arrest Focus Group
Out-of-hospital cardiac arrest (OHCA) remains associated with poor survival and marked variation in post-resuscitation care. Drawing on discussion from the British Cardiovascular Intervention Society (BCIS) OHCA focus group, this article summarises five practical considerations for management following return of spontaneous circulation. First, selective conveyance to specialist cardiac arrest centres may be most effective when aligned with the BCIS algorithm, particularly for patients with features suggesting a reversible cardiac cause. Second, early risk stratification with MIRACLE2 may support decision-making when interpreted alongside specialist clinical judgement. Third, early multidisciplinary team review may improve coherence in a complex condition that often spans cardiology, intensive care, neurology and emergency medicine. Fourth, neuroprognostication is likely to be most robust when delayed appropriately, guided by European Resuscitation Council recommendations and delivered through a structured multimodal multidisciplinary team process. Finally, post-survival rehabilitation and family support should be regarded as core components of the OHCA pathway rather than optional afterthoughts.
- 9 September 2026
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
Open AccessFive Practical Considerations for the Management of Out-of-hospital Cardiac Arrest: Reflections from the British Cardiovascular Intervention Society Out-of-hospital Cardiac Arrest Focus Group
Out-of-hospital cardiac arrest (OHCA) remains associated with poor survival and marked variation in post-resuscitation care. Drawing on discussion from the British Cardiovascular Intervention Society (BCIS) OHCA focus group, this article summarises five practical considerations for management following return of spontaneous circulation. First, selective conveyance to specialist cardiac arrest centres may be most effective when aligned with the BCIS algorithm, particularly for patients with features suggesting a reversible cardiac cause. Second, early risk stratification with MIRACLE2 may support decision-making when interpreted alongside specialist clinical judgement. Third, early multidisciplinary team review may improve coherence in a complex condition that often spans cardiology, intensive care, neurology and emergency medicine. Fourth, neuroprognostication is likely to be most robust when delayed appropriately, guided by European Resuscitation Council recommendations and delivered through a structured multimodal multidisciplinary team process. Finally, post-survival rehabilitation and family support should be regarded as core components of the OHCA pathway rather than optional afterthoughts.
- 20 May 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (8) , e016735
Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease
BACKGROUND: Intravascular imaging (IVI) during percutaneous coronary intervention (PCI) improves outcomes. Pullback pressure gradient characterizes coronary artery disease patterns as focal or diffuse; however, the benefit of IVI across this spectrum remains incompletely understood. We aimed to evaluate clinical outcomes after PCI with or without IVI guidance in patients with focal and diffuse disease defined by pullback pressure gradient. METHODS: Prospective, multicenter, single-arm study of 811 patients (840 vessels) undergoing PCI. Pullback pressure gradient was calculated from manual fractional flow reserve pullbacks to define focal (pullback pressure gradient ≥0.62) or diffuse coronary artery disease. IVI use was at the operator’s discretion. The primary outcome was target vessel failure at 1-year follow-up. RESULTS: IVI-guided PCI was performed in 41% of patients. In the overall cohort, target vessel failure was lower with IVI guidance (adjusted hazard ratio, 0.60 [95% CI, 0.36–0.99]; P =0.044), with a lower incidence of cardiac death ( P =0.042). The results were consistent irrespective of the baseline coronary artery disease pattern ( P interaction =0.128). Among patients with focal disease, IVI-guided PCI was associated with a significantly lower incidence of target vessel failure compared with non-IVI-guided PCI (hazard ratio, 0.41 [95% CI, 0.18–0.91]; P =0.029). There was no statistical difference in target vessel failure with the use of IVI among patients with diffuse disease (hazard ratio, 0.91 [95% CI, 0.48–1.73]; P =0.771). CONCLUSIONS: In patients undergoing physiology-guided PCI, the use of IVI reduced clinical events at 1 year. These findings suggest that the benefit of IVI extends across the full spectrum of coronary artery disease.
- 20 May 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (8) , e016735
Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease
BACKGROUND: Intravascular imaging (IVI) during percutaneous coronary intervention (PCI) improves outcomes. Pullback pressure gradient characterizes coronary artery disease patterns as focal or diffuse; however, the benefit of IVI across this spectrum remains incompletely understood. We aimed to evaluate clinical outcomes after PCI with or without IVI guidance in patients with focal and diffuse disease defined by pullback pressure gradient. METHODS: Prospective, multicenter, single-arm study of 811 patients (840 vessels) undergoing PCI. Pullback pressure gradient was calculated from manual fractional flow reserve pullbacks to define focal (pullback pressure gradient ≥0.62) or diffuse coronary artery disease. IVI use was at the operator’s discretion. The primary outcome was target vessel failure at 1-year follow-up. RESULTS: IVI-guided PCI was performed in 41% of patients. In the overall cohort, target vessel failure was lower with IVI guidance (adjusted hazard ratio, 0.60 [95% CI, 0.36–0.99]; P =0.044), with a lower incidence of cardiac death ( P =0.042). The results were consistent irrespective of the baseline coronary artery disease pattern ( P interaction =0.128). Among patients with focal disease, IVI-guided PCI was associated with a significantly lower incidence of target vessel failure compared with non-IVI-guided PCI (hazard ratio, 0.41 [95% CI, 0.18–0.91]; P =0.029). There was no statistical difference in target vessel failure with the use of IVI among patients with diffuse disease (hazard ratio, 0.91 [95% CI, 0.48–1.73]; P =0.771). CONCLUSIONS: In patients undergoing physiology-guided PCI, the use of IVI reduced clinical events at 1 year. These findings suggest that the benefit of IVI extends across the full spectrum of coronary artery disease.
- Open Access
- 15 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (37) , 5247-5265
Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC)
Left main disease represents one of the most complex lesion subsets for percutaneous coronary intervention, associated with an increased risk of serious late complications. The recent endorsement of intracoronary imaging for the guidance of left main bifurcation percutaneous coronary intervention in both acute and chronic coronary syndrome, with respective recommendations in American and European guidelines, reflects the results of recent studies. Patient benefit can only be realized through the interventional community embracing the need for intracoronary imaging-guided planning, guidance and optimization of left main stenting. This clinical consensus statement summarizes the views of a global expert panel, coordinated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the European Bifurcation Club (EBC). The document includes an appraisal of the most contemporary evidence and provides clinical guidance on how to maximize the benefit of intravascular ultrasound or optical coherence tomography in the treatment of left main bifurcation disease.
- 15 May 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (37) , 5247-5265
Open AccessIntracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC)
Left main disease represents one of the most complex lesion subsets for percutaneous coronary intervention, associated with an increased risk of serious late complications. The recent endorsement of intracoronary imaging for the guidance of left main bifurcation percutaneous coronary intervention in both acute and chronic coronary syndrome, with respective recommendations in American and European guidelines, reflects the results of recent studies. Patient benefit can only be realized through the interventional community embracing the need for intracoronary imaging-guided planning, guidance and optimization of left main stenting. This clinical consensus statement summarizes the views of a global expert panel, coordinated by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the European Bifurcation Club (EBC). The document includes an appraisal of the most contemporary evidence and provides clinical guidance on how to maximize the benefit of intravascular ultrasound or optical coherence tomography in the treatment of left main bifurcation disease.
- Open Access
- 27 April 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102750
Postdilation Strategies Following Provisional Stenting of Left Main Coronary Bifurcations
- 27 April 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102750
Open AccessPostdilation Strategies Following Provisional Stenting of Left Main Coronary Bifurcations
- Open Access
- 22 December 2025
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20
All-comEr Registry of OCT (AERO) to Investigate the MLD-MAX Algorithm for OCT-guided-precision-PCI in Daily Routine: Rationale and Study Design of ILUMIEN-V-AERO
Background: Despite class 1 recommendations and clinical evidence supporting optical coherence tomography (OCT), its adoption is limited. While randomised controlled trials show clinical benefits of OCT under strict protocols, its real-world performance is unclear. Aims and methods: All-comEr Registry of OCT (AERO) to Investigate the MLD-MAX Algorithm for OCT-guided-precision-PCI in Daily Routine (ILUMIEN-V-AERO; NCT05324683) is a prospective, multicentre OCT registry aiming to recruit 2,000 patients across sites in the UK, Germany and Saudi Arabia. The study seeks to evaluate the real-world use of an algorithmic approach to OCT-guided percutaneous coronary intervention (PCI) (MLD-MAX) and directly compares its outcomes to those from the ILUMIEN-IV randomised controlled trial. The primary endpoint for this comparison is post-PCI minimum stent area relative to the reference segments. Secondary endpoints include OCT imaging assessments (minimum stent area, edge dissection, stent malapposition, mean stent expansion, plaque protrusion, reference segment disease), procedural outcomes (procedural and fluoroscopy time, contrast use, renal replacement therapy) and clinical endpoints (a composite endpoint of target lesion failure [cardiac death, ischaemia-driven target lesion revascularisation, target vessel MI] and unplanned hospitalisation for unstable angina). All patients will undergo clinical follow-up at 30 days and 6 months to assess target lesion failure. Beyond the inclusion criteria of the ILUMIEN-IV trial, this study will explore the role of OCT in diagnosing acute coronary syndrome, its application in guiding drug-coated balloon PCI and the impact of core laboratory support and critical evaluation on operator performance. Conclusion: ILUMIEN-V-AERO is a large, prospective registry designed to assess the real-world performance of OCT and provide insights into its role in underexplored areas of PCI guidance.
- 22 December 2025
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20
Open AccessAll-comEr Registry of OCT (AERO) to Investigate the MLD-MAX Algorithm for OCT-guided-precision-PCI in Daily Routine: Rationale and Study Design of ILUMIEN-V-AERO
Background: Despite class 1 recommendations and clinical evidence supporting optical coherence tomography (OCT), its adoption is limited. While randomised controlled trials show clinical benefits of OCT under strict protocols, its real-world performance is unclear. Aims and methods: All-comEr Registry of OCT (AERO) to Investigate the MLD-MAX Algorithm for OCT-guided-precision-PCI in Daily Routine (ILUMIEN-V-AERO; NCT05324683) is a prospective, multicentre OCT registry aiming to recruit 2,000 patients across sites in the UK, Germany and Saudi Arabia. The study seeks to evaluate the real-world use of an algorithmic approach to OCT-guided percutaneous coronary intervention (PCI) (MLD-MAX) and directly compares its outcomes to those from the ILUMIEN-IV randomised controlled trial. The primary endpoint for this comparison is post-PCI minimum stent area relative to the reference segments. Secondary endpoints include OCT imaging assessments (minimum stent area, edge dissection, stent malapposition, mean stent expansion, plaque protrusion, reference segment disease), procedural outcomes (procedural and fluoroscopy time, contrast use, renal replacement therapy) and clinical endpoints (a composite endpoint of target lesion failure [cardiac death, ischaemia-driven target lesion revascularisation, target vessel MI] and unplanned hospitalisation for unstable angina). All patients will undergo clinical follow-up at 30 days and 6 months to assess target lesion failure. Beyond the inclusion criteria of the ILUMIEN-IV trial, this study will explore the role of OCT in diagnosing acute coronary syndrome, its application in guiding drug-coated balloon PCI and the impact of core laboratory support and critical evaluation on operator performance. Conclusion: ILUMIEN-V-AERO is a large, prospective registry designed to assess the real-world performance of OCT and provide insights into its role in underexplored areas of PCI guidance.
- Open Access
- 4 July 2025
- Published by Elsevier in Hellenic Journal of Cardiology
Iatrogenic coronary artery dissections: direct visualization and mechanistic insights from the visible heart laboratories
- 4 July 2025
- Published by Elsevier in Hellenic Journal of Cardiology
Open AccessIatrogenic coronary artery dissections: direct visualization and mechanistic insights from the visible heart laboratories
- Open Access
Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical Outcomes
- Open Access
- 1 May 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (5)
High-Definition Intravascular Ultrasound Versus Optical Coherence Tomography: Lumen Size and Plaque Morphology
- 1 May 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (5)
Open AccessHigh-Definition Intravascular Ultrasound Versus Optical Coherence Tomography: Lumen Size and Plaque Morphology
- Open Access
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102523
Can AI Capture and Quantify Clinical Expertise? Implications for Intracoronary Imaging in Percutaneous Coronary Intervention
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102523
Open AccessCan AI Capture and Quantify Clinical Expertise? Implications for Intracoronary Imaging in Percutaneous Coronary Intervention